TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results
At Youthful Infusion Med Spa, were proud to offer treatments like semaglutide and tirzepatide as part of our integrative approach to health and wellness
The image was captured with an infrared-sensitive EMCCD camera (IXON DU885K) and displayed on a monitor
Adding targeted nutritional support through a quality glucagon-like peptide-1 supplement can amplify these efforts when chosen thoughtfully